TLR4, NF-κB, NLRP3, and caspase-1 mRNA expression were all increased in the AD + PhM + COMB group as opposed to the AD group by 84%, 79%, 83%, and 83%, respectively. This evidence concerns the gene NLRP3 and Alzheimer disease.